Nukleus Office Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/08/2026 ,inter alia, to consider and approve 1. To consider, formulate, ....

Nukleus Office Solutions Limited CIN NO -L70101DL2019PLC355618 │PH: +91-9667049487│ Email: cs@nukleus.work│ Website: www.nukleus.work│ Date: 24.08.2026 BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Mumbai- 400 001 Scrip Code: 544370 Sub.: Prior Intimation of Board Meeting under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir/Ma’am, Pursuant to Regulation 29 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the meeting of the Board of Directors of the Company will be held on Saturday, August 29, 2026 inter alia to consider and approve the following business items: 1. To consider, formulate, and approve the Employee Stock Option Plan / Scheme, 2026 NUKLEUS OFFICE SOLUTIONS LIMITED ESOP Scheme-I 2026, subject to the approval of shareholders and relevant regulatory authorities. 2. To approve the draft notice of the General Meeting to seek necessary shareholder approvals. 3. Any other business item with the permission of the Chair. Further, in terms of the Company's Code of Conduct for Prevention of Insider Trading framed under the SEBI (Prohibition of Insider Trading) Regulations, the Trading Window for dealing in the securities of the Company will remain closed for all Designated Persons and their immediate relatives until 48 hours after the conclusion/outcome of the scheduled Board Meeting. This is for your information and records. Thanking You, For Nukleus Office Solutions Limited Vinay Rathore Membership No. 75848 (Company Secretary & Compliance Officer) Regd. Office: 1102, Barakhamba Tower, 22 Barakhamba Road, Connaught Place, New Delhi, Central Delhi- 110001, Delhi Corporate Office: Plot No 29, Sector -142, Noida, UP – 201305